William Forbes

William Forbes

EVP, Chief Development OfficeratHeron Therapeutics, Inc. /De/· In proxies 2022–2025

Pay in FY2025+10% from the year before · Heron Therapeutics, Inc. /De/ stock -15.0% the same year

William Forbes was paid $1.7M in FY2025 (Dec), up 10%. Heron Therapeutics, Inc. /De/ stock fell 15.0% that year.

Pay$100 in the stock at the end of FY21 → $14
Pay is from the Summary Compensation Table of each Heron Therapeutics, Inc. /De/ proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Heron Therapeutics, Inc. /De/Public company · 4 yr
    • EVP, Chief Development Officer2022 – Present · 4 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?